Cellular reprogramming is a process that involves resetting adult somatic cells to a more youthful state by partially expressing Yamanaka factors (OSKM), which reverses epigenetic aging markers without fully reverting the cells to pluripotency.
Aging-related diseases and tissue degeneration caused by accumulated cellular damage over time.
The technique utilizes transient expression of four key transcription factors: Oct4, Sox2, Klf4, and c-Myc (OSKM). This partial reprogramming process targets specific epigenetic modifications associated with cellular aging, thereby rejuvenating the cells without fully reverting them to a pluripotent state.
The manufacturing of reprogrammed cells involves culturing adult somatic cells in media containing transient expression vectors or chemical cocktails that induce the partial expression of Yamanaka factors.
Cells are first isolated from a donor, then cultured under conditions that allow for the transient expression of OSKM. This process is carefully controlled to avoid full reprogramming and pluripotency induction.
Curated names only — none are invented. Use the link to find more.
Cost drivers only — no verified dollar figures are shown. Check live sources for prices.
Illustrative — search real, dated examples rather than trusting a generated story.
Live searches — we don't list papers we can't verify.
Live patent searches — filings are never listed from memory.
Verify against primary sources only.
Source: curated technology intelligence stream with tracked references.